Azuma F
Jpn J Antibiot. 1976 Feb;29(2):197-200.
This paper reports the clinical trial of amoxicillin. (1) A daily dose of 750 approximately 1,000 mg of amoxicillin was orally administered for 3 approximately 12 days to 20 patients, 7 of which were with acute suppurative tympanitis, 3 with furuncle of the ear, 2 with furuncle of the nose and 8 with acute amygdalitis. As a result, amoxicillin proved remarkably effective or effective in 17 patients (85.0%). (2) Amoxicillin was effective against: Staphylococcus aureus in 10 of 11 patients (90.9%) Staphylococcus epidermidis in 2 of 2 patients (100%) Streptococcus hemolyticus in 3 of 4 patients (75%) Streptococcus viridans in 1 of 1 patient (100%) Diplococcus pneumoniae in 1 of 1 patient (100%) (3) Although one patient developed drug eruption, there were no side effects that necessitated cessation of administration. From the above results, it is concluded that amoxicillin can be used in the treatment of otorhinolaryngologic infections.
本文报道了阿莫西林的临床试验。(1)对20例患者口服给予每日剂量约750至1000毫克的阿莫西林,疗程为3至12天,其中7例患有急性化脓性中耳炎,3例患有耳部疖肿,2例患有鼻部疖肿,8例患有急性扁桃体炎。结果显示,阿莫西林在17例患者(85.0%)中显示出显著疗效或有效。(2)阿莫西林对以下细菌有效:11例患者中有10例(90.9%)对金黄色葡萄球菌有效;2例患者中有2例(100%)对表皮葡萄球菌有效;4例患者中有3例(75%)对溶血性链球菌有效;1例患者中有1例(100%)对草绿色链球菌有效;1例患者中有1例(100%)对肺炎双球菌有效。(3)尽管有1例患者出现了药疹,但没有出现需要停药的副作用。根据上述结果,得出结论:阿莫西林可用于治疗耳鼻咽喉科感染。